GeneTex
United States (US)

Lipocalin-2 recombinant protein

Lipocalin-2-recombinant-protein_WB_GTX65155-1_18121411_437.jpg

Cat No. GTX65155

Application WB
Reactivity Human
Species Human
APPLICATION

Calculated MW

20 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Storage

Reconstitute in water to a concentration 0.1-1 mg/ml. The solution can then be further diluted to other aqueous solutions. Store at -20ºC.

Antigen Species

Human

Region/Sequence

Amino acids 21-198 of Lipocalin-2 protein.

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥95%) and by HPLC (≥95%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

LCN2, 25 kDa alpha -2-microglob, p25, Neutrophil gelatinaseassociated lipocalin, Neutrophil gelatinase-associated lipocalin, 25 kDa alpha 2microglob, 25 kDa alpha2microglob, NGAL, 25 kDa alpha 2 microglob

Background

Lipocalin-2 (LCN-2), a secreted glycoprotein, is an adipokine that potentially connects obesity and its related adipose inflammation. Lipocalin-2 has also been implicated in a variety of processes including cell differentiation, tumorigenesis, and apoptosis. The recombinant human Lipocalin-2 consisting of 178 amino acids (a.a. 21-198, Accession# NP_00555) was expressed from E. coli and purified using proprietary technology.

Research Area

DATA IMAGES
Lipocalin-2-recombinant-protein_WB_GTX65155-1_18121411_437.jpg

GTX65155 WB Image

Purity of recombinant human Lipocalin-2 (2 µg) was analyzed by reduced SDS-PAGE electrophoresis.